Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical Proteomics is Scopus-indexed (Q2, CiteScore 6), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1542-6416Verify ISSN ↗1559-0275Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Clinical Biochemistry | 44 / 124 | 64th | Q2 |
| Molecular Biology | 182 / 414 | 56th | Q2 |
| Molecular Medicine | 83 / 179 | 53rd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present (also 2004), best quartile Q2, CiteScore 6.
Clinical Proteomics is Q2 in Clinical Biochemistry (rank 44 of 124), Q2 in Molecular Biology (rank 182 of 414) and Q2 in Molecular Medicine (rank 83 of 179), by CiteScore 2025.
Clinical Proteomics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6, which places it in quartile Q2 at the 64th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.041, quartile Q2, with an H-index of 49.
The publisher lists an article processing charge of about US$2,490 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical Proteomics is published by BioMed Central Ltd. Its print ISSN is 1542-6416 and its online ISSN is 1559-0275.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Clinical Proteomics has an h-index of 58 and a 2-year mean of 4.45 citations per paper (OpenAlex). Its Scopus CiteScore is 6, quartile Q2. On 2-year citations it ranks #22 of 121 Scopus journals in Clinical Biochemistry.
Clinical Proteomics published 53 papers in 2025; its busiest recent year was 2024 with 69. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (36%), United States (17%) and India (4.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.